Market Tracker

07/31 3:07am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

7.89
Data as of Jul 30
 +0.09 / +1.15%
Today’s Change
1.68
Today|||52-Week Range
9.56
+213.10%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close7.80
Today’s open7.85
Day’s range7.65 - 7.94
Volume228,871
Average volume (3 months)819,654
Market cap$294.6M
Dividend yield--
Data as of 3:59pm ET, 07/30/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+47.86%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc0.000.00%
TGTXTG Therapeutics Inc+0.23+2.90%
RGLSRegulus Therapeutics...+0.08+1.22%
FOLDAmicus Therapeutics ...+0.12+2.75%
Data as of 3:59pm ET, 07/30/2014

Financials

Next reporting dateAugust 11, 2014
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts